Yarrow Bioscience Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.2% | +59.0% | +109.3% | -43.4% | +18.4% | -28.5% | -39.2% | +139.7% | -31.5% | -54.9% | |
| – | -28.1% | +102.5% | +118.4% | -43.9% | +11.4% | -27.6% | -39.4% | +150.7% | -32.9% | -53.4% | |
| – | -90.8% | +153.4% | +385.1% | -37.8% | +87.0% | -26.6% | -26.8% | -0.9% | -34.9% | +20.6% | |
| – | -29.4% | +102.1% | +118.1% | -43.5% | -23.9% | -27.9% | -26.8% | +201.7% | -34.0% | -52.8% | |
| – | – | – | – | – | – | -52.1% | -34.1% | – | – | – | |
| – | – | – | – | – | – | -1.5% | – | – | – | – | |
| – | +19.5% | +73.3% | -92.3% | +11.6% | +427.6% | -67.3% | -48.1% | -6.3% | +65.6% | -83.8% | |
| – | +406.9% | +100.3% | +22.1% | +11.7% | +104.2% | -15.4% | -49.2% | -19.3% | +96.6% | -83.8% | |
| – | – | – | – | – | +8.1% | -53.9% | – | – | -13.9% | – | |
| – | +139.6% | +61.3% | +33.6% | +14.6% | +26.8% | +36.2% | -63.3% | -30.5% | +63.2% | -61.5% | |
| – | – | – | – | -47.5% | -45.3% | +29.7% | -35.8% | +184.4% | -41.3% | -46.7% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.2% | +0.0% | -5.7% | +56.6% | +282.1% | +58.7% | +11.4% | +222.4% | +314.6% | +0.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.